Search by Drug Name or NDC
NDC 61919-0087-15 ONDANSETRON 8 mg/1 Details
ONDANSETRON 8 mg/1
ONDANSETRON is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct_Rx. The primary component is ONDANSETRON HYDROCHLORIDE.
MedlinePlus Drug Summary
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
Related Packages: 61919-0087-15Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ondansetron
Product Information
NDC | 61919-0087 |
---|---|
Product ID | 61919-087_f901a3ab-ec8f-7d86-e053-6394a90a3bee |
Associated GPIs | 50250065050320 |
GCN Sequence Number | 016393 |
GCN Sequence Number Description | ondansetron HCl TABLET 8 MG ORAL |
HIC3 | H6J |
HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
GCN | 20042 |
HICL Sequence Number | 006055 |
HICL Sequence Number Description | ONDANSETRON HCL |
Brand/Generic | Generic |
Proprietary Name | ONDANSETRON |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | ONDANSETRON |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, FILM COATED |
Route | ORAL |
Active Ingredient Strength | 8 |
Active Ingredient Units | mg/1 |
Substance Name | ONDANSETRON HYDROCHLORIDE |
Labeler Name | Direct_Rx |
Pharmaceutical Class | Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA078539 |
Listing Certified Through | 2024-12-31 |
Package
NDC 61919-0087-15 (61919008715)
NDC Package Code | 61919-087-15 |
---|---|
Billing NDC | 61919008715 |
Package | 15 TABLET, FILM COATED in 1 BOTTLE (61919-087-15) |
Marketing Start Date | 2019-08-29 |
NDC Exclude Flag | N |
Pricing Information | N/A |